Related Experiment Video
Updated: Jun 15, 2026
02:28
Measuring Psoriasis Severity at Home
Published on: March 1, 2024
[Bone turnover markers evaluation in psoriatic arthritis].
Camelia Ciacli1, Maria Puşchiţă, Doina Drugărin
1Universitatea de Vest "V. Goldiş" Arad, Facultatea de Medicină, Clinica de Medicină internă - Imunologie, Spitalul Clinic Judeţean Arad.
Summary
Psoriatic arthritis patients show higher bone turnover markers, including osteoprotegerin (OPG) and bone alkaline phosphatase (Bone-ALP), with a negative correlation to receptor activator of NF-kappa B ligand (RANKL). This suggests a complex bone remodeling process in the disease.
Area of Science:
- Rheumatology and Immunology
- Bone Metabolism Research
Context:
- Psoriatic arthritis (PsA) is a chronic inflammatory disease affecting joints and skin.
- Bone remodeling imbalances are implicated in PsA pathogenesis, but specific marker correlations require further elucidation.
Purpose:
- To investigate serum levels of key bone turnover markers: osteoprotegerin (OPG), bone alkaline phosphatase (Bone-ALP), and receptor activator of NF-kappa B ligand (RANKL).
- To explore the relationship between these markers and psoriatic arthritis activity.
Summary:
- Patients with psoriatic arthritis exhibited significantly higher peripheral blood levels of OPG, Bone-ALP, and RANKL compared to healthy controls.
- A strong negative correlation was observed between OPG and RANKL, and between Bone-ALP and RANKL.
- These findings indicate a complex interplay of bone formation and resorption markers in PsA.
Impact:
- The study highlights the potential of OPG, Bone-ALP, and RANKL as biomarkers for assessing disease activity in psoriatic arthritis.
- Early determination of these markers could aid in precise evaluation and guide future targeted treatment strategies for PsA.
